332 Followers on Owler

Jounce Therapeutics is engaged in the discovery and development of a pipeline of cancer immunotherapy treatments for a range of cancers...

Read more

Jounce Therapeutics is engaged in the discovery and development of a pipeline of cancer immunotherapy treatments for a range of cancers...

Read more
Jounce President & CEO: Richard Murray

President & CEO

Richard Murray

CEO Approval Rating

77/100

Annual Revenue
$53.8M
Employees
140
Funding
296.1M

Jounce Quarterly and Annual Revenue

Coming soon for Jounce!

Annual Revenue

$53.8M

Jounce's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 53.8M.

Jounce News

Jounce Press Releases

Jounce Videos

Jounce Headquarters

780 Memorial Drive

Cambridge, Massachusetts02139

857-259-3840

Driving Directions »

Jounce Summary

ABOUT

Overview

Jounce Therapeutics is engaged in the discovery and development of a pipeline of cancer immunotherapy treatments for a range of cancers. Jounce was founded in 2012. Jounce's headquarters is located in Cambridge, Massachusetts, USA 02139. Jounce's Pre...

CEO

Jounce's President & CEO, Richard Murray, currently has an approval rating of 77%. Jounce's primary competitors are NexImmune,

Acquisitions

There have been no acquisitions found related to Jounce

Investments

Recent investment data cannot be found related to Jounce

Frequently Asked Questions about Jounce

  1. When was Jounce founded?

    Jounce was founded in 2012
  2. Who is Jounce's CEO?

    Jounce's CEO is Richard Murray
  3. How much revenue does Jounce generate?

    Jounce generates $53.8M in revenue
  4. How much funding does Jounce have?

    Jounce has historically raised $296.1M in funding
  1. Where is Jounce's headquarters?

    Jounce's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Jounce have?

    Jounce has 140 employees
  3. What sector does Jounce operate in?

    Jounce is in Biotechnology
  4. Who are Jounce's competitors?

    Jounce's top competitors are NexImmune

Trending Companies